-
Product Insights
NewTheralink Technologies Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Theralink Technologies Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Theralink Technologies Inc (Theralink Technologies) is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products comprise biosimilars and vaccines developed for cancer types such as gynecologic cancer, pancreatic cancer, colorectal cancer, breast, prostrate and other cancers. Theralink Technologies intends to help improve cancer outcomes for patients, reveal therapeutic options for oncologists, and support biopharmaceutical drug development....
-
Product Insights
Avant Diagnostics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Avant Diagnostics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Avant Diagnostics Inc (Avant Diagnostics) operates as a healthcare data generating technology company that provides biomarker testing services that are being planned or developed in multiple areas of oncology. The company’s products include Theralink, a tumor biomarker platform that enables physicians to make personalized treatment recommendation for cancer patients and enables early and late state drug development for pharmaceutical...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OvcaVax
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry OvcaVax Drug Details OvcaVax was under development for the treatment of breast and drug...
-
Product Insights
Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Drugs In Development, 2022, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood...
-
Product Insights
Pancreatic Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Pancreatic Cancer Diagnostic Tests include assays of mostly antibodies released in response to a pancreatic cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Pancreatic Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Pancreatic Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Product Insights
Colorectal Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Colorectal Cancer Diagnostic Tests are used for detection of CRC based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient’s sample. GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Colorectal Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Colorectal Cancer Diagnostic Tests Pipeline Assessment report provides key information and...
-
Product Insights
Lung Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Lung Cancer Diagnostic Tests include assays of mostly antibodies released in response to a lung cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Lung Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Lung Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Lung Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Product Insights
Breast Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Breast Cancer Diagnostic Tests are used for detection of cancer based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient’s sample. GlobalData's Medical Devices sector report, “Breast Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Breast Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Breast Cancer Diagnostic Tests Pipeline Assessment report provides key information and...